ESMO PracticeUpdate Conference Series:
Videos from #ESMO20 on Melanoma
Key Takeaways from ESMO: updates on immunotherapy for melanoma
- There was some key data on immunotherapy for metastatic melanoma presented at this year's ESMO. Could you describe some of the most relevant findings?
- Was this complete response predictive of long-term outcomes? - How would this impact clinical practice?
- Was there any data presented at ESMO that might help address the needs of these relatively less responsive patients?
- What other combinations were presented at ESMO this year?
Key Takeaways from ESMO: Updates in Targeted Therapy for Melanoma
Alexander CJ van Akkooi
- What are the most exciting updates in targeted therapy for metastatic melanoma from this conference?
- Did we learn anything new about adjuvant treatment from these presentations?
- Finally, are there any novel targeted therapies that we should keep our eyes on?
The ESMO PU Conference Series – A collaboration brought to you by Elsevier’s PracticeUpdate and the European Society for Medical Oncology.